Dengue Fever Archives - Infectious Disease Advisor

Vector-borne Illnesses

Eight-Gene Model Can Help Predict Progression to Severe Dengue

April 5, 2022

An eight-gene model can help predict progression to severe dengue (SD), according to a study published online.

COVID19

Low Dengue Incidence in 2020 Due to COVID-19-Related Disruption

March 21, 2022

Dengue incidence was low in 2020, which was attributable to COVID-19-related disruption, according to a study published online.

Vector-borne Illnesses

Efficacy of the TAK-003 Vaccine for Protection Against Dengue Fever in Children, Adolescents

By

Jessica Nye, PhD

November 3, 2021

Researchers conducted a study to determine whether the TAK-003 vaccine effectively protects against dengue fever in children and adolescents for up to 3 years.

Vector-borne Illnesses

Risk Predictors of Dengue Disease Progression During the Febrile Phase

By

Joyce Lee, PharmD, RPh

April 30, 2021

Study authors searched medical databases to identify factors that could be detected in the febrile phase associated with progression to severe dengue disease.

Vector-borne Illnesses

Climate Change Ushers in Era of Uncertainty for Infectious Diseases

By

Cindy Lampner, MSLIS

September 11, 2020

A high frequency of climate-change associated severe weather events have created an increased human-to-human transmission risk for novel diseases.

Emerging Diseases

11 Dengue Fever Cases Confirmed in Florida Keys

July 16, 2020

Confirmation of an 11th case of dengue fever in the Florida Keys.

Zika Virus

Diagnostics in Patients At Risk for Both Dengue and Zika Infection

By

Bradley van Paridon

July 12, 2019

The CDC has summarized present and updated guidelines on dengue and Zika virus diagnostic testing in patients with a clinically compatible illness who live in or recently traveled to an endemic area.

Vector-borne Illnesses

Dengue Vaccine Candidate TAK-003 Looks Promising in Phase 3 Trial

January 30, 2019

The TIDES trial is investigating the safety and efficacy of 2 doses of TAK-003 in preventing dengue fever caused by any of the 4 dengue virus serotypes.

Emerging Diseases

Dengue Vaccine Candidate Gets FDA’s Priority Review

By

Steve Duffy

November 5, 2018

Two Phase 3 trials conducted in Asia and Latin America assessed the efficacy of the vaccine in >35,000 individuals aged 2 to 16 years.

Prevention

Dengue Detection and Preparedness Plan for 2020 Olympic Games in Tokyo

By

Zahra Masoud

November 1, 2018

The failure mode and effect analysis methodology may facilitate protocols for new control that would benefit dengue detection and assessment for the 2020 Olympics.